The microtubule cytoskeleton: An old validated target for novel therapeutic drugs

Laurence Lafanechère1

  • 1Team Cytoskeleton Dynamics and Nuclear Functions, Institute for Advanced Biosciences, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Grenoble, France.

Insights

Compounds targeting microtubules are crucial for cancer therapy but cause side effects. New research focuses on improved microtubule-targeting drugs for cancer and other diseases like neuronal disorders and infections.

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology
  • Cell Biology

Background:

  • Microtubule-targeting compounds are established cancer therapeutics.
  • Current therapies exhibit significant adverse effects due to targeting non-cancerous cells.
  • Advancements in understanding tubulin structure and microtubule dynamics are key.

Purpose of the Study:

  • To review recent advances in microtubule-targeting drugs.
  • To explore emerging therapeutic strategies beyond cancer treatment.
  • To highlight the collaborative efforts of chemists and biologists in drug development.

Main Methods:

  • Review of current literature on microtubule-targeting agents.
  • Analysis of drug mechanisms of action, including established drugs like colchicine.
  • Examination of new therapeutic approaches for various diseases.

Main Results:

  • Emerging therapeutic strategies target microtubule dynamics for improved efficacy and reduced toxicity.
  • New drug candidates show potential for treating cancer, neuronal diseases, heart conditions, and parasitic infections.
  • Understanding drug mechanisms, such as colchicine and kinase inhibitors, aids in developing novel agents.

Conclusions:

  • Targeting the microtubule cytoskeleton offers promising therapeutic avenues for diverse diseases.
  • Interdisciplinary collaboration is accelerating the development of safer and more effective microtubule-targeting drugs.
  • Future research will likely yield improved treatments by refining our knowledge of microtubule regulation.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.5K